For: | Di Giorgio A, Tulone A, Nicastro E, Norsa L, Sonzogni A, D'Antiga L. Use of oral vancomycin in children with autoimmune liver disease: A single centre experience. World J Hepatol 2021; 13(12): 2113-2127 [PMID: 35070012 DOI: 10.4254/wjh.v13.i12.2113] |
---|---|
URL: | https://www.wjgnet.com/1948-5182/full/v13/i12/2113.htm |
Number | Citing Articles |
1 |
Alessandra Elvevi, Alice Laffusa, Camilla Gallo, Pietro Invernizzi, Sara Massironi. Any Role for Microbiota in Cholangiocarcinoma? A Comprehensive Review. Cells 2023; 12(3): 370 doi: 10.3390/cells12030370
|
2 |
Cristo Yared Pérez Martin, José Ramón Alberto Alonso, Jenifer González Chávez, María Pilar Díaz Ruiz, Marta Suárez González, Javier Merino Alonso. [Translated article] Oral vancomycin in a pediatric patient with primary sclerosing cholangitis and inflammatory bowel disease. Farmacia Hospitalaria 2023; 47(6): T297 doi: 10.1016/j.farma.2023.09.005
|
3 |
Eva Vlčková, Katarína Mitrová. Sclerosing cholangitis in children with inflammatory bowel disease. Česko-slovenská pediatrie 2023; 78(3): 182 doi: 10.55095/CSPediatrie2023/025
|
4 |
Kai Markus Schneider, Martin Kummen, Palak J. Trivedi, Johannes R. Hov. Role of microbiome in autoimmune liver diseases. Hepatology 2024; 80(4): 965 doi: 10.1097/HEP.0000000000000506
|
5 |
Cristo Yared Pérez Martin, José Ramón Alberto Alonso, Jenifer González Chávez, María Pilar Díaz Ruiz, Marta Suárez González, Javier Merino Alonso. Vancomicina oral en un paciente pediátrico con colangitis esclerosante primaria y enfermedad inflamatoria intestinal. Farmacia Hospitalaria 2023; 47(6): 297 doi: 10.1016/j.farma.2023.06.015
|